Pharmaceutical compositions containing amisulpride and their therapeutic applications
US6069165A · kind A · utility
23Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 1999 |
| Grant date | May 30, 2000 |
| Priority date | — |
| Expiry date | Mar 16, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition, comprising a lipophilic phase and, as active principle, at least one compound selected from PA1 an optically active isomer or a racemate of amisulpride; PA1 an optically active isomer or a racemate of a pharmaceutically acceptable acid addition salt of amisulpride; PA1 an optically active isomer or a racemate of a quaternary ammonium salt of amisulpride; and PA1 an optically active isomer or a racemate of an oxide of amisulpride.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.